NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia
· Delayed Price · Currency is AUD 0.110
+0.005 (4.76%)
Apr 29, 2026, 12:49 PM AEST
ASX:NSB Revenue
NeuroScientific Biopharmaceuticals had revenue of 317.91K AUD in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 317.91K, down -85.63% year-over-year.
Revenue (ttm)
317.91K
Revenue Growth
-85.63%
P/S Ratio
109.85
Revenue / Employee
n/a
Employees
n/a
Market Cap
34.92M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Avecho Biotechnology | 1.24M |
| EZZ Life Science Holdings | 61.40M |
| Imugene | 3.94M |
| Proteomics International Laboratories | 3.21M |
| Entropy Neurodynamics | 1.58M |
| Prescient Therapeutics | 4.27M |
| Noxopharm | 3.40M |
| Neurizon Therapeutics | 5.98M |
NeuroScientific Biopharmaceuticals News
- 5 months ago - NeuroScientific Biopharmaceuticals Transcript: Investor Update - Transcripts